Decoding 18 Analyst Evaluations For DexCom
Decoding 18 Analyst Evaluations For DexCom
解讀德康醫療的18個分析師評估
The perception of DexCom by financial experts is...DexCom (NASDAQ:DXCM) has been analyzed by 18 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在過去三個月中，德康醫療（納斯達克股票代碼：DXCM）已經受到18位分析師的分析，揭示出從看好到看淡的多種觀點。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $104.22, a high estimate of $145.00, and a low estimate of $75.00. A 24.99% drop is evident in the current average compared to the previous average price target of $138.94.
營業收入增長：在爲期3個月的時間段內，德康醫療（DexCom）表現積極，實現了15.26%的營業收入增長率，截至2024年6月30日。這反映了該公司頂線收益的大幅增長。與同行相比，營業收入增長率落後於行業板塊內的同行。該公司的增長率低於同行的平均水平，主要集中在醫療保健板塊。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級：詳細剖析
The perception of DexCom by financial experts is...
資產回報率（RO...
登入免費觀看全文
登入/註冊